ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 37 filers reported holding ARGOS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $1,000 | -50.0% | 11,900 | 0.0% | 0.00% | – |
Q3 2017 | $2,000 | -50.0% | 11,900 | 0.0% | 0.00% | – |
Q2 2017 | $4,000 | -95.1% | 11,900 | -93.5% | 0.00% | – |
Q1 2017 | $82,000 | -90.6% | 184,194 | +3.8% | 0.00% | – |
Q4 2016 | $870,000 | +10.5% | 177,494 | +11.7% | 0.00% | – |
Q3 2016 | $787,000 | +6.2% | 158,869 | +31.3% | 0.00% | – |
Q2 2016 | $741,000 | +179.6% | 120,996 | +356.5% | 0.00% | – |
Q1 2014 | $265,000 | – | 26,507 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pharmstandard International S.A. | 13,242,279 | $5,984,000 | 15.97% |
Pharmstandard International S.A. | 5,120,604 | $2,314,000 | 6.17% |
SANDERS MORRIS HARRIS LLC | 290,424 | $132,000 | 0.02% |
WEDBUSH SECURITIES INC | 63,500 | $29,000 | 0.00% |
Virtu KCG Holdings LLC | 127,073 | $57,000 | 0.00% |
Alyeska Investment Group, L.P. | 200,000 | $90,000 | 0.00% |
WASATCH ADVISORS LP | 186,900 | $85,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 157,707 | $71,000 | 0.00% |
SG Americas Securities, LLC | 17,652 | $8,000 | 0.00% |
BlackRock Inc. | 795,101 | $360,000 | 0.00% |